GLUCOCORTICOIDS

Open Access
Topicals for Psoriasis: Classical Drugs, New Concepts, and New Medications
Juan Raul Castro-Ayarza and Manuel Dario Franco

The Journal of Rheumatology September 1 2026, 53 (Suppl 2) 12-14; DOI: https://doi.org/10.3899/jrheum.2026-0440
You have access
Association of Daily Glucocorticoid Dose With Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Data From the Almenara Lupus Cohort
Anubhav Singh, Rocío V. Gamboa-Cárdenas, Victor R. Pimentel-Quiroz, Zoila Rodriguez-Bellido, Cesar Pastor-Asurza, Risto Perich-Campos, Graciela S. Alarcón and Manuel F. Ugarte-Gil

The Journal of Rheumatology September 1 2026, 53 (9) 986-991; DOI: https://doi.org/10.3899/jrheum.2025-0394
You have access
Assessment of Giant Cell Arteritis–Associated Visual Outcomes at a Tertiary Hospital in Ontario, Canada
Mats L. Junek, Rahul Chanchlani, Amadeo R. Rodriguez, Nader Khalidi and Amber O. Molnar

The Journal of Rheumatology December 1 2025, 52 (12) 1274-1280; DOI: https://doi.org/10.3899/jrheum.2025-0459
You have access
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases
Karin Furukawa, Kaichi Kaneko, Mai Kawazoe, Kotaro Shikano, Takahiko Sugihara and Toshihiro Nanki

The Journal of Rheumatology September 1 2025, 52 (9) 927-933; DOI: https://doi.org/10.3899/jrheum.2024-1321
You have access
Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society
Hiroya Tamai, Sora Ito, Satoshi Takanashi, Yasushi Kondo and Yuko Kaneko

The Journal of Rheumatology July 1 2025, 52 (7) 662-668; DOI: https://doi.org/10.3899/jrheum.2024-1126
You have access
Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse Events
Fumika N. Nagase, Sho Fukui, Naoho Takizawa, Toshihiro Yamaguchi, Nobuhiro Oda, Hajime Inokuchi, Takanori Ito, Mitsuru Watanabe, Masei Suda, Yoichiro Haji, Yasuhiro Suyama, Ryo Rokutanda, Masahiro Minoda, Atsushi Nomura, Eishi Uechi and Hiromichi Tamaki

The Journal of Rheumatology March 1 2025, 52 (3) 270-279; DOI: https://doi.org/10.3899/jrheum.2024-0612
You have access
Symptom Severity and Glucocorticoid Dosing in Patients With Polymyalgia Rheumatica and Obesity
Marco A. Cimmino, Cynthia S. Crowson, Bhaskar Dasgupta, Michael Schirmer, Christian Dejaco, Carlo Salvarani, Eric L. Matteson and Dario Camellino

The Journal of Rheumatology February 1 2025, 52 (2) 151-157; DOI: https://doi.org/10.3899/jrheum.2024-0353
You have access
Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus
Sofie A.M. Gernaat, Julia F. Simard, Anna-Karin Wikström, Elisabet Svenungsson and Elizabeth V. Arkema

The Journal of Rheumatology May 1 2022, 49 (5) 465-469; DOI: https://doi.org/10.3899/jrheum.210087
You have access
Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use
Mary Safy-Khan, Maria J.H. de Hair, Paco M.J. Welsing, Jacob M. van Laar and Johannes W.G. Jacobs the Society for Rheumatology Research Utrecht (SRU)

The Journal of Rheumatology October 1 2021, 48 (10) 1504-1507; DOI: https://doi.org/10.3899/jrheum.200213
You have access
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis
Anael Dumont, Jean-Jacques Parienti, Claire Delmas, Jonathan Boutemy, Gwénola Maigné, Nicolas Martin Silva, Audrey Sultan, Gaétane Planchard, Achille Aouba and Hubert de Boysson

The Journal of Rheumatology January 1 2020, 47 (1) 108-116; DOI: https://doi.org/10.3899/jrheum.181127

Main menu

User menu

Search

GLUCOCORTICOIDS

Pages

Content

Resources

Subscribers

More